BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stepanova M, Locklear T, Rafiq N, Mishra A, Venkatesan C, Younossi ZM. Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry. Clin Transplant 2016;30:1570-7. [DOI: 10.1111/ctr.12859] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Buganza-torio E, Doucette KE. Management of Viral Hepatitis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 2018;32:635-50. [DOI: 10.1016/j.idc.2018.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Liu CH, Chen YS, Wang SS, Liu CJ, Su TH, Yang HC, Hong CM, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus Infection. Clin Infect Dis 2018;66:289-92. [PMID: 29020359 DOI: 10.1093/cid/cix787] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
3 Somerville L, Doucette K. Hepatitis C: Current Controversies and Future Potential in Solid Organ Transplantation. Curr Infect Dis Rep 2018;20:18. [PMID: 29789956 DOI: 10.1007/s11908-018-0625-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Martin EF. Paradigm Shift in Utilization of Livers from Hepatitis C-Viremic Donors into Hepatitis C Virus-Negative Patients. Clin Liver Dis 2021;25:195-207. [PMID: 33978579 DOI: 10.1016/j.cld.2020.08.009] [Reference Citation Analysis]
5 de Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, de Miguel-Yanes JM, Méndez-Bailón M, López-de-Andres A. National Trends In Kidney, Heart And Liver Transplants Among Patients With And Without Chronic Obstructive Pulmonary Disease In Spain (2001-2015). Int J Chron Obstruct Pulmon Dis 2019;14:2235-43. [PMID: 31576119 DOI: 10.2147/COPD.S213257] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Zalawadiya SK, Lindenfeld J, Shah A, Wigger M, Danter M, Brinkley DM, Menachem J, Punnoose L, Balsara K, Brown Sacks S, Ooi H, Perri R, Awad J, Smith S, Fowler R, O'Dell H, Darragh C, Ruzevich-Scholl S, Schlendorf K. Trends in Renal Function Among Heart Transplant Recipients of Donor-Derived Hepatitis C Virus. ASAIO J 2020;66:553-8. [PMID: 31425256 DOI: 10.1097/MAT.0000000000001034] [Reference Citation Analysis]
7 Sanaka S, Kasarala GR, Tillmann HL. A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression. J Infect Dis 2018;217:857-60. [PMID: 29365131 DOI: 10.1093/infdis/jix659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Iyengar A, Han J, Helmers M, Kelly JJ, Patrick W, Chung JJ, Goel N, Birati EY, Atluri P. Relationship Between Change in Heart Transplant Volume and Outcomes: A National Analysis. J Card Fail 2020;26:515-21. [PMID: 31770633 DOI: 10.1016/j.cardfail.2019.11.023] [Reference Citation Analysis]
9 Aslam S, Grossi P, Schlendorf KH, Holm AM, Woolley AE, Blumberg E, Mehra MR; working group members. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant 2020;39:418-32. [PMID: 32362393 DOI: 10.1016/j.healun.2020.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
10 Lampert BC, Kissling K. Approaches and strategies to manage the hepatitis C virus-positive heart donor. Curr Opin Organ Transplant 2022;27:229-34. [PMID: 35649114 DOI: 10.1097/MOT.0000000000000984] [Reference Citation Analysis]
11 Chen C, Yuan Z. Prevalence and risk factors for prehypertension and hypertension among adults in Central China from 2000-2011. Clin Exp Hypertens 2018;40:734-43. [PMID: 29513624 DOI: 10.1080/10641963.2018.1431252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tong CKW, Khush KK. New Approaches to Donor Selection and Preparation in Heart Transplantation. Curr Treat Options Cardiovasc Med 2021;23:28. [PMID: 33776401 DOI: 10.1007/s11936-021-00906-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O'Conner K, Reese P, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Am J Transplant. 2017;17:2790-2802. [PMID: 28556422 DOI: 10.1111/ajt.14381] [Cited by in Crossref: 227] [Cited by in F6Publishing: 197] [Article Influence: 45.4] [Reference Citation Analysis]
14 Khush KK. Donor selection in the modern era. Ann Cardiothorac Surg 2018;7:126-34. [PMID: 29492390 DOI: 10.21037/acs.2017.09.09] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]